| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Teresa L. Young is See Remarks at MCRB. From October 2023 to February 2026, the filings on record show 0 open-market purchases and 12 sales. Teresa L. Young's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $17K at current prices.
Historically, Teresa L. Young's trades have earned a strong insider score of 72/100 across 12 rated trades. Over a 12-month horizon, 70.0% of those trades were profitable, with an average 12-month return of +17.9%.
The MCRB filings lean toward selling, a net 40,487 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 3,374 | $1.08 | $3,643.92 | -17.7% | -12.0% | -20.7% | |
| Oct 30, 2023 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 2,907 | $1.35 | $3,924.45 | -25.6% | -13.8% | -46.8% |